Circulating microparticles and endothelial progenitor cells in atherosclerosis: Pharmacological effects of irbesartan

Journal of Thrombosis and Haemostasis

Volumn 10, Issue 4, 2012, Pages 680-691

  Georgescu, A ^a,b   Alexandru, N ^a,b   Andrei, E ^b   Titorencu, I ^a,b   Dragan, E ^b   Tarziu, C ^c   Ghiorghe, S ^c   Badila, E ^c   Bartos, D ^c   Popov, D ^b  

^a PETRU PONI INSTITUTE OF MACROMOLECULAR CHEMISTRY   (Romania)

^b INSTITUTE OF CELLULAR BIOLOGY AND PATHOLOGY NICOLAE SIMIONESCU   (Romania)

^c Emergency Hospital   (Romania)

Author keywords

Atherosclerosis; Circulating microparticles; Endothelial progenitor cells; Irbesartan; Vascular dysfunction

Indexed keywords

CHOLESTEROL; COLLAGEN TYPE 1; COLLAGEN TYPE 3; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GELATINASE A; GELATINASE B; INTERLEUKIN 6; IRBESARTAN; MACROPHAGE ELASTASE; MONOCYTE CHEMOTACTIC PROTEIN 1; PADGEM PROTEIN; RANTES; THROMBOPLASTIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRIACYLGLYCEROL; VON WILLEBRAND FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIOLE; ARTERY WALL; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; DRUG EFFICACY; ENDOTHELIAL MICROPARTICLE; ENDOTHELIAL PROGENITOR CELL; HEART RATE; HYPERCHOLESTEROLEMIA; HYPERTENSION; MALE; NONHUMAN; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; VASCULAR DISEASE;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; ATHEROSCLEROSIS; BIPHENYL COMPOUNDS; BLOOD PRESSURE; CELL-DERIVED MICROPARTICLES; CHOLESTEROL; CRICETINAE; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; FIBRILLAR COLLAGENS; HEART RATE; HYPERCHOLESTEROLEMIA; HYPERTENSION; INFLAMMATION MEDIATORS; MALE; MATRIX METALLOPROTEINASES; MESOCRICETUS; STEM CELLS; TETRAZOLES; TISSUE INHIBITOR OF METALLOPROTEINASES; TRIGLYCERIDES; VASOCONSTRICTION; VASODILATION;

EID: 84859185167     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2012.04650.x     Document Type: Article

References (29)

1. Xu Q. Mouse models of arteriosclerosis: from arterial injuries to vascular grafts. Am J Pathol 2004; 165: 1-10.
2. Woywodt A, Bahlmann FH, De Groot K, Haller H, Haubitz M. Circulating endothelial cells: life, death, detachment and repair of the endothelial cell layer. Nephrol Dial Transplant 2002; 17: 1728-30.
3. Mallat Z, Benamer H, Hugel B, Benessiano J, Steg PG, Freyssinet JM, Tedgui A. Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation 2000; 101: 841-3.
4. Chironi GN, Boulanger CM, Simon A, Dignat-George F, Freyssinet J-M, Tedgui A. Endothelial microparticles in diseases. Cell Tissue Res 2009; 335: 143-51.
5. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275: 964-7.
6. Xu Q. Progenitor cells in vascular repair. Curr Opin Lipidol 2007; 18: 534-9.
7. Hristov M, Weber C. Progenitor cell trafficking in the vascular wall. J Thromb Haemost 2009; 7: 31-4.
8. Aicher A, Heeschen C, Mildner-Rihm C, Urbich C, Ihling C, Technau-Ihling K, Zeiher AM, Dimmeler S. Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat Med 2003; 9: 1370-6.
9. Wassmann S, Czech T, van Eickels M, Fleming I, Bohm M, Nickenig G. Inhibition of diet-induced atherosclerosis and endothelial dysfunction in apolipoprotein E/angiotensin II type 1A receptor double-knockout mice. Circulation 2004; 110: 3062-7.
10. Calhoun DA, Zhu S-T, Chen Y-F, Oparil S. Gender and dietary NaCl in spontaneously hypertensive and Wistar-Kyoto rats. Hypertension 1995; 26: 285-9.
11. Riveiro A, Mosquera A, Alonso M, Calvo C. Angiotensin II type 1 receptor blocker irbesartan ameliorates vascular function in spontaneously hypertensive rats regardless of oestrogen status. J Hypertens 2002; 20: 1365-72.
12. Boulanger CM, Scoazec A, Ebrahimian T, Henry P, Mathieu E, Tedgui A, Mallat Z. Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction. Circulation 2001; 104: 2649-52.
13. Heiss C, Keymel S, Niesler U, Ziemann J, Kelm M, Kalka C. Impaired progenitor cell activity in age-related endothelial dysfunction. J Am Coll Cardiol 2005; 45: 1458-60.
14. Georgescu A, Alexandru N, Constantinescu E, Popov D. Effect of gap junction uncoupler heptanol on resistance arteries reactivity in experimental models of diabetes, hyperlipemia and hyperlipemia-diabetes. Vascul Pharmacol 2006; 44: 513-8.
15. 2- adrenoceptor. Pharmacology 2008; 81: 110-7.
16. Mulvany MJ, Halpern W. Contractile properties of small arteriolar resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res 1977; 41: 19-26.
17. Li AC, Palinski W. Peroxisome proliferator-activated receptors: how their effects on macrophages can lead to the development of a new drug therapy against atherosclerosis. Annu Rev Pharmacol Toxicol 2006; 46: 1-39.
18. Sanz M, Ganado P, Tejerina T. Two angiotensin AT1 receptor antagonists, irbesartan and losartan, effects in cholesterol-fed rabbits. Eur J Pharmacol 2002; 442: 99-106.
19. Delas Heras N, Martin-Fernandez B, Miana M, Ballesteros S, Oubina MP, Lopez-Farre AJ, Cachofeiro V, Lahera V. The protective effect of irbesartan in rats fed a high fat diet is associated with modification of leptin-adiponectin imbalance. J Hypertens 2009; 27: 37-41.
20. Alexandru N, Popov D, Dragan E, Andrei E, Georgescu A. Platelet activation in hypertension associated with hypercholesterolemia; effects of irbersartan. J Thromb Haemost, 2011; 9: 173-84.
21. Blake GJ, Ridker PM. Novel clinical markers of vascular wall inflammation. Circ Res 2001; 89: 763-71.
22. Agouni A, Mostefai HA, Porro C, Carusio N, Favre J, Richard V, Henrion D, Martínez MC, Andriantsitohaina R. Sonic hedgehog carried by microparticles corrects endothelial injury through nitric oxide release. FASEB J 2007; 21: 2735-41.
23. Benameur T, Andriantsitohaina R, Martínez MC. Therapeutic potential of plasma membrane-derived microparticles. Pharmacol Rep 2009; 61: 49-57.
24. Howes LG, Abbot D, Straznicky NE. Lipoproteins and cardiovascular reactivity. Br J Clin Pharmacol 1997; 44: 319-24.
25. Georgescu A, Popov D. The contractile response of the mesenteric resistance arteries to prostaglandin F2a; effects of simultaneous hyperlipemia- diabetes. Fundam Clin Pharmacol 2003; 17: 683-9.
26. Georgescu A, Alexandru N, Popov D, Amuzescu M, Andrei E, Zamfir C, Maniu H, Badila A. Chronic venous insufficiency is associated with elevated level of circulating microparticles. J Thromb Haemost 2009; 7: 1566-75.
27. Pfister SL. Role of platelet microparticles in the production of thromboxane by rabbit pulmonary artery. Hypertension 2004; 41: 211-7.
28. Barry OP, Kazanietz MG, Pratico D, FitzGerald GA. Arachidonic acid in platelet microparticles up-regulates cyclooxygenase-2- dependent prostaglandin formation via a protein kinase C/mitogen activated protein-kinase dependent pathway. J Biol Chem 1999; 274: 7545-6.
29. Timmermans F, Plum J, Yöder MC, Ingram DA, Vandekerckhove B, Case J. Endothelial progenitor cells: identity defined? J Cell Mol Med 2009; 13: 87-102.